Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Gabriel

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Human Gene Therapy Methods|May 8, 2012
Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sitesAnne Arens, Jens-Uwe Appelt, Cynthia C Bartholomae, et al.
Life Sciences|July 11, 2019
Pacemaker cell characteristics of differentiated and HCN4-transduced human mesenchymal stem cellsFabrice F Darche, Rasmus Rivinius, Eva Köllensperger, et al.
Nature Biotechnology|August 9, 2011
An unbiased genome-wide analysis of zinc-finger nuclease specificityRichard Gabriel, Angelo Lombardo, Anne Arens, et al.
Human Gene Therapy|December 30, 2014
Fanconi anemia gene editing by the CRISPR/Cas9 systemMark J Osborn, Richard Gabriel, Beau R Webber, et al.
Research and Practice in Thrombosis and Haemostasis|February 27, 2026
Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trialRobert Klamroth, Paul E Monahan, Paul Van der Valk, et al.
Biomedicines|July 27, 2024
Restoration of T and B Cell Differentiation after RAG1 Gene Transfer in Human RAG1 Defective Hematopoietic Stem CellsNataël Sorel, Francisco Díaz-Pascual, Boris Bessot, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 3, 2013
TALEN-based gene correction for epidermolysis bullosaMark J Osborn, Colby G Starker, Amber N McElroy, et al.
Immunity|December 8, 2021
Interleukin-10 receptor signaling promotes the maintenance of a PD-1<sup>int</sup> TCF-1<sup>+</sup> CD8<sup>+</sup> T cell population that sustains anti-tumor immunityBola S Hanna, Laura Llaó-Cid, Murat Iskar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2015
Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL NucleasesMark J Osborn, Beau R Webber, Friederike Knipping, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapyAnnette Deichmann, Martijn H Brugman, Cynthia C Bartholomae, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Human Gene Therapy Methods|May 8, 2012
Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sitesAnne Arens, Jens-Uwe Appelt, Cynthia C Bartholomae, et al.
Life Sciences|July 11, 2019
Pacemaker cell characteristics of differentiated and HCN4-transduced human mesenchymal stem cellsFabrice F Darche, Rasmus Rivinius, Eva Köllensperger, et al.
Nature Biotechnology|August 9, 2011
An unbiased genome-wide analysis of zinc-finger nuclease specificityRichard Gabriel, Angelo Lombardo, Anne Arens, et al.
Human Gene Therapy|December 30, 2014
Fanconi anemia gene editing by the CRISPR/Cas9 systemMark J Osborn, Richard Gabriel, Beau R Webber, et al.
Research and Practice in Thrombosis and Haemostasis|February 27, 2026
Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trialRobert Klamroth, Paul E Monahan, Paul Van der Valk, et al.
Biomedicines|July 27, 2024
Restoration of T and B Cell Differentiation after RAG1 Gene Transfer in Human RAG1 Defective Hematopoietic Stem CellsNataël Sorel, Francisco Díaz-Pascual, Boris Bessot, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 3, 2013
TALEN-based gene correction for epidermolysis bullosaMark J Osborn, Colby G Starker, Amber N McElroy, et al.
Immunity|December 8, 2021
Interleukin-10 receptor signaling promotes the maintenance of a PD-1<sup>int</sup> TCF-1<sup>+</sup> CD8<sup>+</sup> T cell population that sustains anti-tumor immunityBola S Hanna, Laura Llaó-Cid, Murat Iskar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2015
Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL NucleasesMark J Osborn, Beau R Webber, Friederike Knipping, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapyAnnette Deichmann, Martijn H Brugman, Cynthia C Bartholomae, et al.
Pageof 4